Stockreport

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Revvity, Inc.  (RVTY) 
PDF Initiative spans an IVD assay and a new Revvity Omics lab-developed test to expand clinical testing for early-stage disease screening WALTHAM, Mass.--(BUSINESS WIRE)- [Read more]